With regard to Mifegymiso, since January 1, 2016: (a) what studies have been conducted by, or on behalf of, Health Canada on the side effects of Mifegymiso, including (i) the date, (ii) the methodology, (iii) who conducted the study, (iv) the location, (v) the findings; and (b) what data has been collected on the side effects of Mifegymiso, broken down by (i) each of the known side effects of Mifegymiso, (ii) Health Canada's estimate on the number of Canadians affected by each of the known side effects of Mifegymiso?
In the House of Commons on November 14th, 2022. See this statement in context.